Achalasia

Area of Science:

• Gastroenterology
• Pediatric Motility Disorders
• Esophageal Diseases

Background:

• Achalasia is a rare neurogenic esophageal motility disorder affecting children, characterized by aperistalsis, hypertensive lower esophageal sphincter (LES), and impaired LES relaxation.
• Symptoms include progressive dysphagia, weight loss, and regurgitation, significantly impacting children's quality of life.
• Current management strategies are often based on adult data, highlighting a need for pediatric-specific insights.

Purpose of the Study:

• To review the current understanding of achalasia pathogenesis in children.
• To discuss advancements in therapeutic techniques for pediatric achalasia.
• To explore existing controversies in the management of this condition.

Main Methods:

• Literature review of pediatric achalasia studies.
• Analysis of evolving treatment modalities, including surgical and endoscopic options.
• Discussion of clinical data extrapolation from adult to pediatric populations.

Main Results:

• Achalasia pathogenesis involves complex neurogenic factors affecting esophageal motility.
• Treatment options have progressed from less invasive methods to minimally invasive surgeries and endoscopic myotomies.
• Significant variations exist in management approaches, with ongoing debate regarding optimal pediatric care.

Conclusions:

• A comprehensive understanding of pediatric achalasia pathogenesis is crucial for effective management.
• Emerging therapeutic techniques offer promising alternatives, but require further pediatric-specific validation.
• Addressing management controversies is essential for optimizing outcomes in children with achalasia.